| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alight, Inc. / Delaware | Director | Class A Common Stock | 62,572 | $351,028 | $5.61 | 02 Jul 2025 | Direct |
| NGM BIOPHARMACEUTICALS INC | President and CFO | Common Stock | 76,000 | $101,840 | $1.34 | 02 Mar 2023 | Direct |
| NGM BIOPHARMACEUTICALS INC | President and CFO | Stock Option (Right to Buy) | 200,000 | 02 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALIT | Alight, Inc. / Delaware | 02 Jul 2025 | 1 | $0 | 4 | Director | 07 Jul 2025, 17:12 |
| ALIT | Alight, Inc. / Delaware | 15 Jan 2025 | 1 | $0 | 4 | Director | 17 Jan 2025, 17:56 |
| ALIT | Alight, Inc. / Delaware | 02 Jan 2024 | 1 | $0 | 4 | Director | 03 Jan 2024, 17:25 |
| ALIT | Alight, Inc. / Delaware | 01 Jan 2024 | 0 | $0 | 3 | Director | 03 Jan 2024, 17:22 |
| /report/000120919123016401-nolan-mangini-siobhan-2023-03-02 | NGM BIOPHARMACEUTICALS INC | 02 Mar 2023 | 3 | $0 | 4 | President and CFO | 06 Mar 2023, 16:12 |
| /report/000120919122040348-nolan-mangini-siobhan-2022-07-01 | NGM BIOPHARMACEUTICALS INC | 01 Jul 2022 | 1 | $0 | 4 | President and CFO | 01 Jul 2022, 18:36 |
| /report/000120919122016186-nolan-mangini-siobhan-2022-03-03 | NGM BIOPHARMACEUTICALS INC | 03 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 04 Mar 2022, 15:05 |